Mitsubishi Chemical Group Corporation

DB:M3C Stock Report

Market Cap: €8.5b

Mitsubishi Chemical Group Valuation

Is M3C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of M3C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: M3C (€6.09) is trading below our estimate of future cash flow value (€8.57)

Significantly Below Future Cash Flow Value: M3C is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for M3C?

Key metric: As M3C is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for M3C. This is calculated by dividing M3C's market cap by their current revenue.
What is M3C's PS Ratio?
PS Ratio0.4x
SalesJP¥3.70t
Market CapJP¥1.58t

Price to Sales Ratio vs Peers

How does M3C's PS Ratio compare to its peers?

The above table shows the PS ratio for M3C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
BAS BASF
0.7x2.96%€42.2b
LXS LANXESS
0.2x3.28%€1.3b
EVK Evonik Industries
0.6x2.09%€7.9b
1COV Covestro
1x5.87%€12.4b
M3C Mitsubishi Chemical Group
0.4x3.27%€1.6t

Price-To-Sales vs Peers: M3C is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.6x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does M3C's PS Ratio compare vs other companies in the DE Chemicals Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7M8 EcoRub
0.09xn/aUS$37.52m
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
M3C 0.4xIndustry Avg. 1.0xNo. of Companies5PS00.40.81.21.62+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: M3C is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is M3C's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M3C PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: M3C is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst M3C forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€6.09
€6.44
+5.79%
20.53%€9.21€4.33n/a11
Jul ’27€5.88
€6.20
+5.33%
22.06%€9.19€4.32n/a11
Jun ’27€5.73
€5.38
-6.02%
16.25%€7.03€4.27n/a12
May ’27€4.87
€5.28
+8.56%
16.08%€6.95€4.23n/a12
Apr ’27€5.03
€5.40
+7.31%
16.70%€7.09€4.31n/a11
Mar ’27€6.10
€5.33
-12.60%
16.69%€7.05€4.29n/a11
Feb ’27€5.37
€5.26
-2.04%
17.83%€7.09€4.31n/a11
Jan ’27€4.85
€5.07
+4.42%
19.34%€7.07€3.81n/a11
Dec ’26€4.68
€5.00
+6.97%
17.29%€7.18€3.87n/a11
Nov ’26€4.40
€5.07
+15.26%
17.60%€7.32€3.94n/a11
Oct ’26€4.78
€5.30
+10.83%
17.47%€7.46€4.02n/a10
Sep ’26€4.91
€5.35
+9.03%
17.47%€7.54€4.06n/a10
Aug ’26€4.42
€5.41
+22.26%
17.47%€7.61€4.10n/a10
Jul ’26€4.30
€5.42
+26.22%
18.53%€7.69€4.14€5.889
Jun ’26€4.52
€5.85
+29.35%
25.22%€7.96€3.67€5.737
May ’26€4.14
€6.06
+46.45%
23.63%€8.00€3.69€4.877
Apr ’26€4.42
€6.19
+39.97%
18.65%€8.05€4.34€5.039
Mar ’26€4.73
€6.46
+36.73%
17.71%€8.35€4.50€6.109
Feb ’26€4.78
€6.41
+33.93%
14.69%€8.10€4.80€5.3711
Jan ’26€4.71
€6.58
+39.73%
14.64%€8.13€4.81€4.8510
Dec ’25€4.86
€6.60
+35.67%
14.93%€8.11€4.80€4.6810
Nov ’25€4.83
€6.37
+31.87%
11.64%€7.84€5.49€4.4010
Oct ’25€5.59
€6.55
+17.26%
12.18%€8.12€5.69€4.7810
Sep ’25€5.14
€6.25
+21.57%
11.86%€8.05€5.51€4.9110
Aug ’25€5.45
€6.16
+12.97%
7.90%€7.12€5.51€4.4210
Jul ’25€5.14
€5.71
+10.97%
9.18%€6.67€4.99€4.309
€6.22
Fair Value
2.0% undervalued intrinsic discount
11
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/28 01:20
End of Day Share Price 2026/07/28 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mitsubishi Chemical Group Corporation is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mikiya YamadaBarclays
Takashi EnomotoBofA Global Research
Yuta NishiyamaCitigroup Inc